Biomedical subjects

Jianping Liu

Publications and source records attributed to Jianping Liu.

At least 19 recordsLinked to original sources

PubMed2024

The Protective Role of DDIT4 in Helicobacter pylori-induced Gastric Metaplasia Through Metabolic Regulation of Ferroptosis.

BACKGROUND & AIMS: Helicobacter pylori (H pylori) infection is a significant factor leading to gastric atrophy, metaplasia and cancer development. Here, we investigated the role of the stress response gene DDIT4 in the pathogenesis of H pylori infection. METHODS: Cell lines, transgenic mice, and human tissue samples were implemented. Proteomics were performed on Ddit4+/+ and Ddit4-/- mice infected with H pylori strain PMSS1. C57BL/6 mice were administered with tamoxifen to induce gastric metaplasia. Stomach tissues were analyzed for histopathologic features, reactive oxygen species, Fe2+, lipid peroxidation, expression of DDIT4, and ferroptosis-related proteins. RESULTS: DDIT4 expression was upregulated at 6 hours but significantly decreased at 24 hours in response to H pylori infection in gastric epithelial cells. Gastric DDIT4 were downregulated in INS-GAS mice at 4 months post H pylori infection. Notably, H pylori infection led to more severe gastric metaplasia lesion in Ddit4-knockout mice. The proteomic profiling revealed an increase in ferroptosis in the gastric tissues of infected Ddit4-deficient mice, compared with infected wild-type mice. Mechanistically, knockout of DDIT4 promoted H pylori-induced ferroptosis through the accumulation of lipid peroxides and ROS levels, and alterations in proteins such as GPX4, ALOX15, and HMOX1. Overexpression of DDIT4 counteracted H pylori-induced stem cell marker CD44V9 through modulation of ferroptosis. Similarly, in another mouse model of gastric metaplasia treated with tamoxifen, as well as in human GIM tissues, we observed the loss of DDIT4 and induction of ferroptosis. CONCLUSIONS: Our results indicate that DDIT4 serves as a protective factor against H pylori-induced gastric metaplasia by metabolic resistance to ferroptosis.

Ferroptosis↗

PubMed2006

Intraplacental choriocarcinoma in a term placenta with both maternal and infantile metastases: a case report and review of the literature.

BACKGROUND: Intraplacental choriocarcinoma is rare, and usually results in maternal metastasis at the time of diagnosis. Intraplacental choriocarcinoma involves both mother and infant is extremely rare. There was only one case report of intraplacental choriocarcinoma with confirmed metastases involving both the mother and the infant. CASE: We describe a second case of intraplacental choriocarcinoma in a term placenta with both maternal and infantile metastases. Grossly, the primary lesion of the placenta resembled an old infarct. Microscopically, clusters of malignant trophoblasts arose from residual normal chorionic villi and infiltrated into the intervillous spaces. Both the mother and the infant received chemotherapy and were alive without disease after one year's follow-up. CONCLUSION: The optimal treatment for intraplacental choriocarcinoma is controversial. However, aggressive chemotherapy is suggested for patients with metastatic disease.

Adult↗

PubMed2006

Characterization of human dopamine responsive protein DRG-1 that binds to p75NTR-associated cell death executor NADE.

Expression of human dopamine responsive gene-1 (DRG-1) is up-regulated in response to treatment of dopamine in the rat astrocytes. However, its functions are not clear up to now. In the presented studies, DRG-1 was identified to be a conserved gene in the vertebrate and expressed abundantly in human testis, brain and skeletal muscle. DRG-1 was shown to interact with human p75NTR-associated cell death executor (NADE) in vivo and in vitro, and the interaction occurred in cytoplasm. The regions required for the interaction were subsequently mapped to the N-terminal of DRG-1 and the C-terminal of NADE. Furthermore, MTT assay showed that stable expression of DRG-1 in 293 cells could promote cell proliferation, and this promotion was suppressed by overexpression of NADE. In flow cytometry cell cycle analysis, overexpression of DRG-1 in 293 or PC12 cells increased the population of cells in the S phase with a concomitant decrease in G0/G1 population. These findings suggest that DRG-1 may contribute to the dopamine-induced cell growth, which is negatively regulated by NADE.

Amino Acid Sequence↗

PubMed2006

The use of Ginkgo biloba extract in acute ischemic stroke.

BACKGROUND: Ginkgo biloba extract is widely used in the treatment of acute ischemic stroke in China. The Cochrane Re-view authors aimed to assess the evidence from randomized controlled trials and quasirandomized controlled trials on the use of Ginkgo biloba extract in acute ischemic stroke. OBJECTIVES: The primary objective is to determine whether Ginkgo biloba extract improves functional outcome without causing undue harm in patients with acute ischemic stroke. Secondary objectives are to assess the effect of Ginkgo biloba extract on neurological impairment and quality of life. SEARCH STRATEGY: The authors searched the Cochrane Stroke Group Trials Register (last searched October 2004), the Trials Register of the Cochrane Complementary Medicine Field (last searched October 2004), and the Chinese Stroke Trials Register (last searched June 2004). In addition,the authors searched the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library Issue 3,2004), MEDLINE (1966 to August 2004), EMBASE (1980 to June 2004), AMED(1985 to May 2002), and the China Biological Medicine Database (CBM-disk,1979 to August 2004). The authors searched relevant clinical trials and re-search registers and contacted pharmaceutical companies and researchers in an ef-fort to identify further published and unpublished studies. SELECTION CRITERIA: Randomized controlled trials or quasirandomized controlled clinical trials comparing Ginkgo biloba extract with placebo or open control(no placebo) in patients with acute ischemic stroke. DATA COLLECTION AND ANALYSIS: Two authors independently selected trials for inclusion, assessed trial quality, and extracted data. MAIN RESULTS: Fourteen trials were identified, of which 10 trials (792 patients)were included. Four trials are awaiting assessment. In the 10 included trials, follow-up was performed at 14 to 35 days after stroke. In all studies, neurological outcome was assessed, but none of them reported on disability (activities of daily living function) or quality of life. Only three trials reported adverse events. In nine trials, all of them assessed to be of inferior quality, significant improvement in neurological deficit at the end of the treatment was used as the outcome measure. When analyzing these trials together, Ginkgo biloba extract was associated with a significant increase in the number of improved patients (Peto odds ratio (OR)2.66; 95% confidence interval (CI): 1.79-3.94). One placebo-controlled trial, assessed to be of good quality, reported neurological outcome as a continuous variable. It failed to show an improvement of neurological deficit at the end of treatment (weighted mean difference (fixed)0.81; 95% CI: -8.9-10.52). No deaths or major adverse events were reported during the follow-up period. CONCLUSIONS: There was no convincing evidence from trials of sufficient methodological quality to support the routine use of Ginkgo biloba extract to promote recovery after stroke. High-quality and large-scale randomized controlled trials are needed to test its efficacy.

Activities of Daily Living↗

PubMed2006

[Adenoidectomy under indirectly visualization with laryngoscope].

OBJECTIVE: To describe the easy-performed, cost-effective adenoidectomy under indirect laryngoscope visualization. METHOD: Fifty-six patients were undergone adenoidectomy. Intra-operatively, soft palate was retracted with catheter, adenoid was indirectly visualized using laryngoscope and removed with adenoid curette. RESULT: All patients were free of snore postoperatively, conductive hearing loss was improved as well. In addition, hearing threshold was stable in two patients with inner ear malformation postoperatively. The blood loss was 20-50 ml, the surgical time was 5-20 min. No patient complained of blood bleed and other complications postoperatively. CONCLUSION: Adenoidectomy under indirect laryngoscope visualization is easy-performed, cost-effective surgical procedures. As well, it is safe and satisfied with surgeons and patients.

Adenoidectomy↗

PubMed2005

Cathepsin B and its interacting proteins, bikunin and TSRC1, correlate with TNF-induced apoptosis of ovarian cancer cells OV-90.

Increasing evidence suggests that lysosomal cysteine proteases cathepsins contribute to the progression of cell apoptosis. Here we found that apoptosis of ovarian cancer cells OV-90 triggered by TNF was cathepsin B-depended. Two cathepsin B binding proteins, bikunin and TSRC1, were identified by yeast two-hybrid method and the interactions were confirmed in vitro and in vivo. Overexpression of bikunin could suppress TNF-induced apoptosis of OV-90 cells, and TSRC1 overexpression had an opposite effect on apoptosis. The presented results suggest that cathepsin B and its interacting proteins, bikunin and TSRC1, are involved in the apoptotic pathway of ovarian cancer cells.

ADAMTS Proteins↗

PubMed2005

Isolation and characterization of ubiquitin-activating enzyme E1-domain containing 1, UBE1DC1.

Ubiquitin and other ubiquitin-like proteins play important roles in post-translational modification. They are phylogenetically well-conserved in eukaryotes. Activated by other proteins, ubiquitin and ubiquitin-like proteins can covalently modify target proteins. The enzymes responsible for the activation of this modification have been known to include UBA1, SAE2, UBA3, SAE1 and ULA1. Here we report a new ubiquitin activating enzyme like cDNA, named ubiquitin activating enzyme E1-domain containing 1 (UBE1DC1), whose cDNA is 2654 base pairs in length and contains an open reading frame encoding 404 amino acids. The UBE1DC1 gene consists of 12 exons and is located at human chromosome 3q22. The result of RT-PCR showed that UBE1DC1 is expressed in most of human tissues.

Amino Acid Sequence↗

PubMed2005

Preparation and pharmacokinetic evaluation of Tashinone IIA solid lipid nanoparticles.

Tashinone IIA loaded solid lipid nanoparticles (TA-SLN) coated with poloxamer 188 was prepared by emulsification/evaporation. The TA-SLN was characterized by transmission electron microscope and dynamic light scattering (DLS). The results showed that the TA-SLN had an average diameter of 98.7 nm with a zeta potential of - 31.6 mv and the drug loading of 4.6% and entrapment efficiency of 87.7%. In vitro release experiment showed that the release of Tashinone IIA from TA-SLN was in accordance with the Weibull equation. The best model fitting experimental data was a two-compartment open model with first-order. The area under curve of plasma concentration-time (AUC) and mean residence time (MRT) of TA-SLN were much higher than those of Tashinone IIA control solution (TA-SOL). The results of pharmacokinetic studies in rabbits indicated that the formulation of TA-SLN was successful in providing a delivery of slow release of Tashinone IIA.

Abietanes↗

PubMed2005

[Digital watermarking for electroencephalogram compression].

In this paper, digital watermarking and EEG compression are introduced firstly, and then a number of digital watermarking methods are explored to resolve the problem of integrality and authenticity in EEG compression. At last, the current state of this technique inside and outside country is summarized and future endeavors are discussed.

Computer Security↗

PubMed2005

[Study on feature extraction of the sleep-multigraph].

Recording the sleep-multigraph is an important method for sleep monitoring and research. In this study, after the all-night sleep in six nights being monitored, the process of sleep is shown by EEG complexity and spectrum feature. It can provide a new path for estimating the sleep quality by sleep staging. Especially, the EEG complexity in different sleep stages is studied. The results indicate that the deeper the sleep, the smaller the EEG complexity of whole cortex. This is of significance to the study on sleep biopsychology.

Electroencephalography↗

PubMed2005

[Auto sleep staging and sleep quality estimation based on BP neural network].

To estimate the sleep quality, a 3-layer BP neural network was studied. The EEG complexity and the power spectrum of sleep-multigraph served as the input vector of the network . All-night sleep-stage scoring was performed. Then several parameters (sleep period, shallow sleep period, deep sleep period, REM period, ratio of the wakeful period and sleep one) were defined to estimate the sleep quality. The experiments revealed that the estimated sleep condition was the same as the subjects' impression. The data on six cases of all-night sleep show that this method is available to estimate the sleep quality.

Electroencephalography↗

PubMed2004

Chinese herbal medicine for severe acute respiratory syndrome: a systematic review and meta-analysis.

OBJECTIVES: To review randomized controlled trials (RCTs) evaluating the effects of Chinese herbal medicine for treating severe acute respiratory syndrome (SARS) systematically. DESIGN: Electronic and manual searches identified RCTs comparing Chinese medicine integrated to conventional medicine versus conventional medicine alone. Methodological quality of trials was assessed by generation of allocation sequence, allocation concealment, blinding, and intention-to-treat. RESULTS: Eight RCTs (488 patients with SARS) were included. The methodological quality was generally low. The combined therapy showed significant reduction of mortality (relative risk 0.32 [95% confidence interval {CI} 0.12 to 0.91]), shortened duration of fever, symptom relief, reductions in chest radiograph abnormalities, and reductions in secondary fungal infections among patients receiving glucocorticoids. There were no significant effects on quality of life or glucocorticoid dosage. CONCLUSION: Chinese herbal medicine combined with conventional medicine may have beneficial effects in patients with SARS. The evidence is insufficient because of the low methodological quality of the included trials.

Drug Therapy, Combination↗

PubMed2004

Cloning, characterization and expression of CDK5RAP1_v3 and CDK5RAP1_v4, two novel splice variants of human CDK5RAP1.

Two novel splice variants of CDK5RAP1, named CDK5RAP1_v3 and CDK5RAP1_v4, were isolated through the large-scale sequencing analysis of a human fetal brain cDNA library. The CDK5RAP1_v3 and CDK5RAP1_v4 cDNAs are 1923bp and 1792bp in length, respectively. Sequence analysis revealed that CDK5RAP1_v4 lacked 1 exon, which was present in CDK5RAP1_v3, with the result that these cDNAs encoded different putative proteins. The deduced proteins were 574 amino acids (designated as CDK5RAP1_v3) and 426 amino acids (CDK5RAP1_v4) in length, and shared the 420 N-terminal amino acids. RT-PCR analysis showed that human CDK5RAP1_v3 was widely expressed in human tissues. The expression level of CDK5RAP1_v3 was relatively high in placenta and lung, whereas low levels of expression were detected in heart, brain, liver, skeletal muscle, pancreas, spleen, thymus, small intestine and peripheral blood leukocytes. In contrast, human CDK5RAP1_v4 was mainly expressed in brain, placenta and testis.

Alternative Splicing↗

PubMed2003

Synthesis of mono- and dihalogenated derivatives of (Me2S)2B12H10 and palladium-catalyzed boron-carbon cross-coupling reactions of the iodides with grignard reagents.

Two series of compounds, 9-X-1,7-(Me(2)S)(2)B(12)H(9) and 9,10-X(2)-1,7-(Me(2)S)(2)B(12)H(8) (X = Cl, Br, I), have been synthesized from reactions of 1,7-(Me(2)S)(2)B(12)H(10) with various halogenating reagents. In addition, reactions of 1,7-(Me(2)S)(2)B(12)H(10) with 2,4-(NO(2))(2)C(6)H(3)SCl and PhSeBr resulted in 9-(2',4'-(NO(2))(2)C(6)H(3)S)-1,7-(Me(2)S)(2)B(12)H(9) and 9,10-(PhSe)(2)-1,7-(Me(2)S)(2)B(12)H(8), respectively. X-ray studies of the dibromo, monoiodo, and aryl thioether derivatives show that electrophilic substitution in 1,7-(Me(2)S)(2)B(12)H(10) takes place at positions 9 and 10, as in the case of the meta-carborane 1,7-C(2)B(10)H(12). From 1,12-(Me(2)S)(2)B(12)H(10) the halides 2-X-1,12-(Me(2)S)(2)B(12)H(9) (X = Br, I) were prepared. For both 1,7- and 1,12-(Me(2)S)(2)B(12)H(10) the best iodination results were obtained using iodine monochloride in refluxing acetonitrile. In the presence of 5 mol % (PPh(3))(2)PdCl(2) the iodides 9-I-1,7-(Me(2)S)(2)B(12)H(9), 2-I-1,12-(Me(2)S)(2)B(12)H(9), and 9,10-I(2)-1,7-(Me(2)S)(2)B(12)H(8) react with RMgX (R = Me, Ph, Bn; X = Cl, Br) in THF to yield the corresponding B-alkyl- and B-aryl-substituted products in good yields without using CuI as a cocatalyst. The bromo derivative 9-Br-1,7-(Me(2)S)(2)B(12)H(9) did not react under similar conditions. No interference from the nearby Me(2)S substituent was observed in palladium-catalyzed substitution of iodide in 2-I-1,12-(Me(2)S)(2)B(12)H(9). Presumably due to the intramolecular activation of an aryl C-H bond of the benzyl substituent in the intermediate palladium complex, the yield of 9,10-Bn(2)-1,7-(Me(2)S)(2)B(12)H(8) was significantly lower than those of the dimethyl and diphenyl derivatives. The molecular structures of 9-R-1,7-(Me(2)S)(2)B(12)H(9) (R = Ph, Bn) and 2-Bn-1,12-(Me(2)S)(2)B(12)H(9) were obtained by single-crystal X-ray analysis.

Journal Article↗

PubMed2003

The solid state structure of [b(10)h(11)](-) and its dynamic NMR spectra in solution.

The structure of [PPh(3)(benzyl)][B(10)H(11)] was determined at -123 degrees C and 24 degrees C by single-crystal X-ray analyses. The B(10) core of [B(10)H(11)](-) is similar in shape to that of [B(10)H(10)](2)(-). The 11th H atom asymmetrically caps a polar face of the cluster and shows no tendency for disorder in the solid state. Variable temperature multinuclear NMR studies shed light on the dynamic nature of [B(10)H(11)](-) in solution. In addition to the fluxionality of the cluster H atoms, the boron cage is fluxional at moderate temperatures, in contrast to [B(10)H(10)](2)(-). Multiple exchange processes are believed to take place as a function of temperature. Results of ab initio calculations are presented. Crystal data: [PPh(3)(benzyl)][B(10)H(11)] at -123 degrees C, P2(1)/c, a = 9.988(2) A, b = 18.860(2) A, c = 15.072(2) A, beta = 107.916(8) degrees, V = 2701.5(7) A(3), Z = 4; [PPh(3)(benzyl)][B(10)H(11)] at 24 degrees C, P2(1)/c, a = 10.067(5) A, b = 19.009(9) A, c = 15.247(7) A, beta = 107.952(9) degrees, V = 2775(2) A(3), Z = 4.

Journal Article↗

PubMed2003

Artificial and bioartificial support systems for acute and acute-on-chronic liver failure: a systematic review.

CONTEXT: Artificial and bioartificial support systems may provide a "bridge" for patients with severe liver disease to recovery or transplantation. OBJECTIVE: To evaluate the effect of artificial and bioartificial support systems for acute and acute-on-chronic liver failure. DATA SOURCES: Randomized trials on any support system vs standard medical therapy were included irrespective of publication status or language. Nonrandomized studies were included in explorative analyses. Trials were identified through electronic searches (Cochrane Hepato-Biliary Group Controlled Trials Register, Cochrane Library, MEDLINE, EMBASE, and the Chinese Medical Database), bibliographies, and contact with experts. Searches were conducted of the entire databases through September 2002. STUDY SELECTION: Of 528 references identified, 12 randomized trials with 483 patients were included. Eight nonrandomized studies were included in explorative analyses. DATA EXTRACTION: Data were extracted and trial quality was assessed independently by 3 reviewers (L.L.K., J.L., B.A-N.). The primary outcome measure was all-cause mortality. Results were combined on the risk ratio (RR) scale. Random-effects models were used. Sources of heterogeneity were explored through meta-regression and stratified meta-analyses. DATA SYNTHESIS: Of the 12 trials included, 10 assessed artificial systems for acute or acute-on-chronic liver failure and 2 assessed bioartificial systems for acute liver failure. Overall, support systems had no significant effect on mortality compared with standard medical therapy (RR, 0.86; 95% confidence interval [CI], 0.65-1.12). Meta-regression indicated that the effect of support systems depended on the type of liver failure (P =.03). In stratified meta-analyses, support systems appeared to reduce mortality by 33% in acute-on-chronic liver failure (RR, 0.67; 95% CI, 0.51-0.90), but not in acute liver failure (RR, 0.95; 95% CI, 0.71-1.29). Compared with randomized trials, nonrandomized studies produced significantly larger estimates of intervention effects (P =.01). CONCLUSION: This review suggests that artificial support systems reduce mortality in acute-on-chronic liver failure compared with standard medical therapy. Artificial and bioartificial support systems did not appear to affect mortality in acute liver failure.

Chronic Disease↗

PubMed2003

Medicinal herbs for hepatitis C virus infection: a Cochrane hepatobiliary systematic review of randomized trials.

OBJECTIVE: The aim of this study was to assess beneficial and harmful effects of medicinal herbs for hepatitis C virus (HCV) infection. METHODS: The databases of the Cochrane Collaboration, MEDLINE, EMBASE, and BIOSIS were searched combined with manual searches of five Chinese and one Japanese journals. We included randomized trials comparing medicinal herbs with placebo, no intervention, nonspecific treatment, other herbs, or interferon and/or ribavirin. Trials of herbs with or without other drug(s) were included. Methodological quality of the trials was evaluated by randomization, double blinding, and the Jadad scale. RESULTS: Thirteen randomized trials (n = 818) evaluated 14 medicinal herbs. Four trials had adequate methodology. Compared with placebo, none of the herbs showed effects on HCV RNA or liver enzyme, except for silybin, which showed a significant reduction of serum AST and gamma-glutamyltranspeptidase levels in one trial. Oxymatrine showed effects on clearance of HCV RNA (relative risk = 9.20, 95% CI = 1.26-67.35) compared with vitamins. The herbal mixture Bing Gan Tang plus interferon-alpha showed better effects on clearance of HCV RNA (relative risk = 2.54, 95% CI = 1.43-4.49) and on normalization of serum ALT (relative risk = 2.54, 95% CI = 1.43-4.49) than interferon-alpha alone. The herbal mixture Yi Zhu decoction showed better effects on clearance of HCV RNA and normalization of ALT compared with glycyrrhizin plus ribavirin. Yi Er Gan Tang showed effects on normalizing serum ALT compared with silymarin plus glucurolactone. The herbs were associated with adverse events. CONCLUSIONS: There is no firm evidence supporting medicinal herbs for HCV infection, and further randomized trials are justified.

Hepacivirus↗

PubMed2003

Radix Sophorae flavescentis for chronic hepatitis B: a systematic review of randomized trials.

To evaluate the effects of radix Sophorae fiavescentis for chronic hepatitis B, a systematic review of randomized clinical trials was conducted. Randomized trials comparing extract of radix Sophorae flavescentis versus placebo, no intervention, non-specific treatment, other active medicines, or interferon for chronic hepatitis B were identified by electronic and manual searches. Trials of Sophorae herb plus other drugs versus other drugs alone were also included. No blinding and language limitations were applied. The methodological quality of trials was assessed by the Jadad scale plus allocation concealment. Meta-analysis was performed where data was available. Twenty-two randomized trials (n = 2409) were included. Methodological quality of the trials was generally low. The combined results showed that matrine (aqueous extract of Sophorae flavescentis) had antiviral activity, positive liver biochemical effects, and improved symptoms and signs compared with non-specific treatment and other herbal medicines. The combination of matrine and interferon-alpha (IFN-alpha), thymosin, or basic treatment showed better effects on viral and liver biochemical responses. The antiviral and biochemical responses were not significantly different between matrine and IFN-alpha. No serious adverse event was reported. Based on the review, Sophorae flavescentis extract (matrine) may have antiviral activity and positive effects on liver biochemistry in chronic hepatitis B. However, the evidence is not sufficient to recommend matrine for routine clinical use due to the generally low methodological quality of the studies. Further rigorous trials are needed.

Alkaloids↗